Earnings FeedTerminal

⌘K

Home/Insiders/FREEMAN SCOTT M

FS

SEC Insider//CIK 0001282731

FREEMAN SCOTT M

CIK 00012827311 companyRICHMOND, CA

Transactions

14

Companies

1

Filings

1

CIK

0001282731

Recent Transactions

14 trades

Sale
ONYX PHARMACEUTICALS INC
Common Stock
2004-04-08$43.57/sh−3,243→ 4,346 total
Exercise/Conversion
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
2004-04-08−5,000→ 10,000 total
Sale
ONYX PHARMACEUTICALS INC
Common Stock
2004-04-08$43.63/sh−300→ 8,814 total
Sale
ONYX PHARMACEUTICALS INC
Common Stock
2004-04-08$43.58/sh−232→ 4,114 total
Exercise/Conversion
ONYX PHARMACEUTICALS INC
Common Stock
2004-04-08$4.00/sh+5,000→ 9,114 total
Sale
ONYX PHARMACEUTICALS INC
Common Stock
2004-04-08$43.60/sh−1,125→ 7,689 total
Sale
ONYX PHARMACEUTICALS INC
Common Stock
2004-04-08$43.61/sh−100→ 7,589 total
Sale
ONYX PHARMACEUTICALS INC
Common Stock
2004-04-08$43.63/sh−300→ 8,814 total
Sale
ONYX PHARMACEUTICALS INC
Common Stock
2004-04-08$43.58/sh−232→ 4,114 total
Exercise/Conversion
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
2004-04-08−5,000→ 10,000 total
Sale
ONYX PHARMACEUTICALS INC
Common Stock
2004-04-08$43.61/sh−100→ 7,589 total
Exercise/Conversion
ONYX PHARMACEUTICALS INC
Common Stock
2004-04-08$4.00/sh+5,000→ 9,114 total
Sale
ONYX PHARMACEUTICALS INC
Common Stock
2004-04-08$43.60/sh−1,125→ 7,689 total
Sale
ONYX PHARMACEUTICALS INC
Common Stock
2004-04-08$43.57/sh−3,243→ 4,346 total

Companies

1

ONYX PHARMACEUTICALS INC
VP, Clinical Research

Recent Filings

1

4
FREEMAN SCOTT M
Apr 9, 2004

Address

C/O ONYX PHARMACEUTICALS, INC. 3031 RESEARCH DR., BUILDING A

RICHMOND, CA, 94806

View on SEC.gov